T-Cell Activation Is an Immune Correlate of Risk in BCG Vaccinated Infants Scientists performed a case–control analysis to identify immune correlates of tuberculosis disease risk in Bacille Calmette–Guerin (BCG) immunized infants from the MVA85A efficacy trial. [Nat Commun] Full Article The Typhoid Toxin Promotes Host Survival and the Establishment of a Persistent Asymptomatic Infection Investigators assessed the effects of the Salmonella enterica genotoxin, known as typhoid toxin, in in vivo models of murine infection. Unexpectedly, the genotoxic subunit’s expression promoted the survival of the host, and was associated with a significant reduction of severe enteritis in the early phases of infection. [PLoS Pathog] Full Article | Press Release Primary Heligmosomoides polygyrus bakeri Infection Induces Myeloid-Derived Suppressor Cells that Suppress CD4+ Th2 Responses and Promote Chronic Infection Scientists observed significant increases in F4/80−CD11bhiGr1hi cells in mesenteric lymph nodes and spleen after primary but not challenge infection; a high proportion of these cells expressed Ly6G and Ly6C. These cells, which phenotypically resemble myeloid-derived suppressor cells, increased in lamina propria early during primary infection. [Mucosal Immunol] Abstract A Novel Therapeutic Strategy of Lipidated Promiscuous Peptide against Mycobacterium tuberculosis by Eliciting Th1 and Th17 Immunity of Host Researchers designed a novel therapeutic strategy by reinforcing the efficacy of drugs to kill Mtb by concurrently boosting host immunity by L91. L91 is chimera of promiscuous epitope of Acr1 antigen of Mtb and TLR-2 agonist Pam2Cys. [Sci Rep] Full Article Long-Lasting Cross-Protection against Influenza a by Neuraminidase and M2e-Based Immunization Strategies Researchers compared protection and CD8+ T cell responses following challenge with H1N1 2009 pandemic and H3N2 viruses of mice that had been immunized with hemagglutinin, neuraminidase and the extracellular domain of matrix protein 2 (M2e) fused to a virus-like particle. [Sci Rep] Full Article HIV CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape Using HIV-1, researchers demonstrated that many insertions and deletions are indeed lethal for the virus, but that others lead to the emergence of replication competent viruses that are resistant to Cas9/single guide RNA. [Cell Rep] Full Article | Graphical Abstract | Editorial 1 | Editorial 2 | Press Release Development of Synthetic Light-Chain Antibodies as Novel and Potent HIV Fusion Inhibitors Scientists developed the first potent and broad light-chain variable domain (VL) single-domain antibody fusion inhibitor of HIV infection. Two anti-HR1 VLs strongly inhibited laboratory-adapted HIV-1 infectivity. [AIDS] Abstract Specific Elimination of Latently HIV-1 Infected Cells Using HIV-1 Protease-Sensitive Toxin Nanocapsules Researchers developed an approach to specifically target and kill cells that are activated early in the process of virus production. By using well-established latent infection models, J-Lat and U1 cells, they demonstrated that only within an HIV-1-producing cell expressing functional HIV-1 protease will the nanocapsule release its ricin A cargo, shutting down viral and cellular protein synthesis, and ultimately leading to rapid death of the producer cell. [PLoS One] Full Article IL-1β and IL-18 Inhibition of HIV-1 Replication in Jurkat Cells and PBMCs Using susceptible lymphocytic cell line, Jurkat cells, and primary peripheral blood mononuclear cells (PBMCs), investigators studied the effects of IL-1β and IL-18 on HIV-1 replication. [Biochem Biophys Res Commun] Abstract Subscribe to our sister publications: Human Immunology News and Immune Regulation News! |